StrongBox Wealth »

Crispr Therapeutics shares owned by StrongBox Wealth

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by StrongBox Wealth from 13F filings

Historical chart of StrongBox Wealth investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by StrongBox Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by StrongBox Wealth

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.5k 64 54.55

More positions owned by StrongBox Wealth

Jpmorgan Ultra-short Income Etf Shs Ben Int (JPST)
Ishares 1-3 Year Treasury Bond Etf Shs Ben Int (SHY)
Alphabet Inc Class A cs (GOOGL)
Capital Group International Equity Etf Shs Ben Int (CGIE)
Invesco Qqq Trust Series I Shs Ben Int (QQQ)
Ishares Msci Usa Quality Factor Etf Shs Ben Int (QUAL)
Ishares Core S&p Mid-cap Etf Shs Ben Int (IJH)
Broadcom (AVGO)
Eaton (ETN)
JPMorgan Chase & Co. (JPM)
Visa (V)
Microsoft Corporation (MSFT)
Costco Wholesale Corporation (COST)
State Street Real Estate Select Sector Spdr Etf Shs Ben Int (XLRE)
Raytheon Technologies Corp (RTX)

View all positions for StrongBox Wealth

Top funds holding Crispr Therapeutics

ARK Investment Management
BlackRock
Orbis Allan Gray
Capital World Investors
State Street Corporation
GSK
Geode Capital Management
Sr One Capital Management
Two Sigma Investments
FMR
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
EcoR1 Capital
UBS Group
Capital Research and Management Company - Division 3

View all funds holding Crispr Therapeutics